{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T03:17:30Z","timestamp":1781752650169,"version":"3.54.5"},"reference-count":151,"publisher":"Spandidos Publications","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Exp Ther Med"],"DOI":"10.3892\/etm.2021.10616","type":"journal-article","created":{"date-parts":[[2021,8,16]],"date-time":"2021-08-16T11:29:41Z","timestamp":1629113381000},"source":"Crossref","is-referenced-by-count":16,"title":["High\u2011dose intravenous immunoglobulins as a therapeutic option in critical illness polyneuropathy accompanying SARS\u2011CoV\u20112 infection: A case\u2011based review of the literature (Review)"],"prefix":"10.3892","volume":"22","author":[{"given":"Adina","family":"Stoian","sequence":"first","affiliation":[{"name":"Department of Pathophysiology, \u2018George Emil Palade\u2019 University of Medicine, Pharmacy, Sciences and Technology, 540136 Targu Mures, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zoltan","family":"Bajko","sequence":"additional","affiliation":[{"name":"Department of Neurology, \u2018George Emil Palade\u2019 University of Medicine, Pharmacy, Sciences and Technology, 540136 Targu Mures, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Smaranda","family":"Maier","sequence":"additional","affiliation":[{"name":"Department of Neurology, \u2018George Emil Palade\u2019 University of Medicine, Pharmacy, Sciences and Technology, 540136 Targu Mures, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roxana","family":"Cioflinc","sequence":"additional","affiliation":[{"name":"1st Neurology Clinic, Mures County Clinical Emergency Hospital, 540136 Targu Mures, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bianca","family":"Grigorescu","sequence":"additional","affiliation":[{"name":"Department of Pathophysiology, \u2018George Emil Palade\u2019 University of Medicine, Pharmacy, Sciences and Technology, 540136 Targu Mures, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anca","family":"Mo\u021b\u0103\u021b\u0103ianu","sequence":"additional","affiliation":[{"name":"Department of Neurology, \u2018George Emil Palade\u2019 University of Medicine, Pharmacy, Sciences and Technology, 540136 Targu Mures, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"B\u0103rcu\u021bean","sequence":"additional","affiliation":[{"name":"Department of Neurology, \u2018George Emil Palade\u2019 University of Medicine, Pharmacy, Sciences and Technology, 540136 Targu Mures, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodica","family":"Bala\u0219a","sequence":"additional","affiliation":[{"name":"Department of Neurology, \u2018George Emil Palade\u2019 University of Medicine, Pharmacy, Sciences and Technology, 540136 Targu Mures, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mircea","family":"Stoian","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology and Intensive Therapy, \u2018George Emil Palade\u2019 University of Medicine, Pharmacy, Sciences and Technology, 540136 Targu Mures, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2249","published-online":{"date-parts":[[2021,8,16]]},"reference":[{"key":"key20210903112807_b1-etm-0-0-10616"},{"issue":"786","key":"key20210903112807_b2-etm-0-0-10616","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-020-05507-4","article-title":"The use of intravenous immunoglobulin gamma for the treatment of severe coronavirus disease 2019: A randomized placebo-controlled double-blind clinical trial","volume":"20","author":"Gharebaghi","year":"2020","journal-title":"BMC Infect Dis"},{"issue":"e1192","key":"key20210903112807_b3-etm-0-0-10616","doi-asserted-by":"publisher","DOI":"10.1002\/cti2.1192","article-title":"Clinical efficacy of intravenous immunoglobulin therapy in critical ill patients with COVID-19: A multicenter retrospective cohort study","volume":"9","author":"Shao","year":"2020","journal-title":"Clin Transl Immunology"},{"key":"key20210903112807_b4-etm-0-0-10616","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1056\/NEJMoa2001017","article-title":"China novel coronavirus investigating and research team: A novel coronavirus from patients with pneumonia in China, 2019","volume":"382","author":"Zhu","year":"2020","journal-title":"N Engl J Med"},{"key":"key20210903112807_b5-etm-0-0-10616","doi-asserted-by":"publisher","first-page":"1708","DOI":"10.1056\/NEJMoa2002032","article-title":"Clinical characteristics of coronavirus disease 2019 in China","volume":"382","author":"Guan","year":"2020","journal-title":"N Engl J Med"},{"key":"key20210903112807_b6-etm-0-0-10616","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","article-title":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","volume":"395","author":"Huang","year":"2020","journal-title":"Lancet"},{"key":"key20210903112807_b7-etm-0-0-10616","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1001\/jama.2020.1585","article-title":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China","volume":"323","author":"Wang","year":"2020","journal-title":"JAMA"},{"key":"key20210903112807_b8-etm-0-0-10616","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1038\/nrneurol.2009.75","article-title":"Critical illness polyneuropathy and myopathy in the intensive care unit","volume":"5","author":"Zink","year":"2009","journal-title":"Nat Rev Neurol"},{"key":"key20210903112807_b9-etm-0-0-10616","author":"Osler"},{"key":"key20210903112807_b10-etm-0-0-10616","first-page":"71","article-title":"Disseminated neuropathy following coma. On the differentation of so-called toxic polyneuropathy","volume":"32","author":"Mertens","year":"1961","journal-title":"Nervenarzt"},{"key":"key20210903112807_b11-etm-0-0-10616","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1136\/jnnp.47.11.1223","article-title":"Polyneuropathy in critically ill patients","volume":"47","author":"Bolton","year":"1984","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"key20210903112807_b12-etm-0-0-10616","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1136\/jnnp.49.5.563","article-title":"Critically ill polyneuropathy: Electrophysiological studies and differentiation from Guillain-Barr\u00e9 syndrome","volume":"49","author":"Bolton","year":"1986","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"key20210903112807_b13-etm-0-0-10616","doi-asserted-by":"publisher","first-page":"1408","DOI":"10.1097\/00003246-199608000-00022","article-title":"Sepsis and the systemic inflammatory response syndrome: Neuromuscular manifestations","volume":"24","author":"Bolton","year":"1996","journal-title":"Crit Care Med"},{"key":"key20210903112807_b14-etm-0-0-10616","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1002\/mus.20304","article-title":"Neuromuscular manifestations of critical illness","volume":"32","author":"Bolton","year":"2005","journal-title":"Muscle Nerve"},{"key":"key20210903112807_b15-etm-0-0-10616","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1017\/S0265021507003262","article-title":"Critical illness myopathy: Sepsis-mediated failure of the peripheral nervous system","volume":"42","author":"Friedrich","year":"2008","journal-title":"Eur J Anaesthesiol Suppl"},{"issue":"238","key":"key20210903112807_b16-etm-0-0-10616","doi-asserted-by":"publisher","DOI":"10.1186\/cc7100","article-title":"Clinical review: Critical illness polyneuropathy and myopathy","volume":"12","author":"Hermans","year":"2008","journal-title":"Crit Care"},{"key":"key20210903112807_b17-etm-0-0-10616","first-page":"325","article-title":"Critical illness neuromyopathies","volume":"88","author":"Lacomis","year":"2002","journal-title":"Adv Neurol"},{"key":"key20210903112807_b18-etm-0-0-10616","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1017\/s031716710001043x","article-title":"The discovery of critical illness polyneuropathy: A memoir","volume":"37","author":"Bolton","year":"2010","journal-title":"Can J Neurol Sci"},{"key":"key20210903112807_b19-etm-0-0-10616","doi-asserted-by":"publisher","first-page":"2809","DOI":"10.1016\/j.clinph.2020.09.017","article-title":"Neuromuscular involvement in COVID-19 critically ill patients","volume":"131","author":"Caba\u00f1es-Mart\u00ednez","year":"2020","journal-title":"Clin Neurophysiol"},{"key":"key20210903112807_b20-etm-0-0-10616","doi-asserted-by":"publisher","first-page":"101","DOI":"10.4103\/1673-5374.125337","article-title":"Critical illness polyneuropathy and myopathy: A systematic review","volume":"9","author":"Zhou","year":"2014","journal-title":"Neural Regen Res"},{"key":"key20210903112807_b21-etm-0-0-10616","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1016\/j.rce.2020.07.003","article-title":"Clinical characteristics of patients hospitalized with COVID-19 in Spain: Results from the SEMI-COVID-19 Registry","volume":"220","author":"Casas-Rojo","year":"2020","journal-title":"Rev Clin Esp"},{"key":"key20210903112807_b22-etm-0-0-10616","doi-asserted-by":"publisher","first-page":"145","DOI":"10.3760\/cma.j.issn.0254-6450.2020.02.003","article-title":"The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) in China","volume":"41","year":"2020","journal-title":"Zhonghua Liu Xing Bing Xue Za Zhi"},{"key":"key20210903112807_b23-etm-0-0-10616","doi-asserted-by":"publisher","first-page":"2859","DOI":"10.1001\/jama.288.22.2859","article-title":"Paresis acquired in the intensive care unit: A prospective multicenter study","volume":"288","author":"De Jonghe","year":"2002","journal-title":"JAMA"},{"key":"key20210903112807_b24-etm-0-0-10616","doi-asserted-by":"publisher","first-page":"2281","DOI":"10.1097\/00003246-200112000-00008","article-title":"Risk factors for the development of polyneuropathy and myopathy in critically ill patients","volume":"29","author":"de Letter","year":"2001","journal-title":"Crit Care Med"},{"key":"key20210903112807_b25-etm-0-0-10616","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1007\/s00134-004-2174-z","article-title":"Does ICU-acquired paresis lengthen weaning from mechanical ventilation?","volume":"30","author":"De Jonghe","year":"2004","journal-title":"Intensive Care Med"},{"key":"key20210903112807_b26-etm-0-0-10616","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1007\/BF02044107","article-title":"Critical illness polyneuropathy in multiple organ dysfunction syndrome and weaning from the ventilator","volume":"22","author":"Leijten","year":"1996","journal-title":"Intensive Care Med"},{"key":"key20210903112807_b27-etm-0-0-10616","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1097\/01.ccm.0000153521.41848.7e","article-title":"Effect of critical illness polyneuropathy on the withdrawal from mechanical ventilation and the length of stay in septic patients","volume":"33","author":"Garnacho-Montero","year":"2005","journal-title":"Crit Care Med"},{"key":"key20210903112807_b28-etm-0-0-10616","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1001\/jama.1995.03530150045032","article-title":"The role of polyneuropathy in motor convalescence after prolonged mechanical ventilation","volume":"274","author":"Leijten","year":"1995","journal-title":"JAMA"},{"key":"key20210903112807_b29-etm-0-0-10616","doi-asserted-by":"publisher","first-page":"1348","DOI":"10.1212\/01.WNL.0000158442.08857.FC","article-title":"Insulin therapy protects the central and peripheral nervous system of intensive care patients","volume":"64","author":"Van den Berghe","year":"2005","journal-title":"Neurology"},{"issue":"R5","key":"key20210903112807_b30-etm-0-0-10616","doi-asserted-by":"publisher","DOI":"10.1186\/cc7694","article-title":"Benefits of intensive insulin therapy on neuromuscular complications in routine daily critical care practice: A retrospective study","volume":"13","author":"Hermans","year":"2009","journal-title":"Crit Care"},{"key":"key20210903112807_b31-etm-0-0-10616","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1164\/rccm.200605-665OC","article-title":"Impact of intensive insulin therapy on neuromuscular complications and ventilator dependency in the medical intensive care unit","volume":"175","author":"Hermans","year":"2007","journal-title":"Am J Respir Crit Care Med"},{"key":"key20210903112807_b32-etm-0-0-10616","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1016\/S1474-4422(11)70178-8","article-title":"Critical illness polyneuropathy and myopathy: A major cause of muscle weakness and paralysis","volume":"10","author":"Latronico","year":"2011","journal-title":"Lancet Neurol"},{"key":"key20210903112807_b33-etm-0-0-10616","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1007\/s00415-005-0654-x","article-title":"Risk factors for critical illness polyneuromyopathy","volume":"252","author":"Bednar\u00edk","year":"2005","journal-title":"J Neurol"},{"key":"key20210903112807_b34-etm-0-0-10616","doi-asserted-by":"publisher","first-page":"1360","DOI":"10.1007\/s001340000586","article-title":"Early signs of critical illness polyneuropathy in ICU patients with systemic inflammatory response syndrome or sepsis","volume":"26","author":"Tennil\u00e4","year":"2000","journal-title":"Intensive Care Med"},{"key":"key20210903112807_b35-etm-0-0-10616","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1097\/01.ccm.0000157969.46388.a2","article-title":"Critical illness polyneuropathy and myopathy in patients with acute respiratory distress syndrome","volume":"33","author":"Bercker","year":"2005","journal-title":"Crit Care Med"},{"key":"key20210903112807_b36-etm-0-0-10616","author":"Hermans"},{"key":"key20210903112807_b37-etm-0-0-10616","doi-asserted-by":"publisher","first-page":"2007","DOI":"10.1097\/01.ccm.0000281450.01881.d8","article-title":"Respiratory weakness is associated with limb weakness and delayed weaning in critical illness","volume":"35","author":"De Jonghe","year":"2007","journal-title":"Crit Care Med"},{"key":"key20210903112807_b38-etm-0-0-10616","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1007\/s00134-005-0029-x","article-title":"Muscle force and fatigue in patients with sepsis and multiorgan failure","volume":"32","author":"Eikermann","year":"2006","journal-title":"Intensive Care Med"},{"key":"key20210903112807_b39-etm-0-0-10616","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/s0022-510x(98)00164-6","article-title":"Clinical and electrophysiological findings in critical illness polyneuropathy","volume":"159","author":"Zifko","year":"1998","journal-title":"J Neurol Sci"},{"key":"key20210903112807_b40-etm-0-0-10616","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1007\/s11940-007-0034-1","article-title":"Diagnosis and management of critical illness polyneuropathy and critical illness myopathy","volume":"9","author":"Bird","year":"2007","journal-title":"Curr Treat Options Neurol"},{"key":"key20210903112807_b41-etm-0-0-10616","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1097\/00075198-200208000-00006","article-title":"Critical illness polyneuropathy","volume":"8","author":"van Mook","year":"2002","journal-title":"Curr Opin Crit Care"},{"key":"key20210903112807_b42-etm-0-0-10616","doi-asserted-by":"publisher","first-page":"1579","DOI":"10.1016\/s0140-6736(96)91074-0","article-title":"Critical illness myopathy and neuropathy","volume":"347","author":"Latronico","year":"1996","journal-title":"Lancet"},{"key":"key20210903112807_b43-etm-0-0-10616","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.1007\/s00134-003-1858-0","article-title":"Critical illness polyneuromyopathy: The electrophysiological components of a complex entity","volume":"29","author":"Bednar\u00edk","year":"2003","journal-title":"Intensive Care Med"},{"issue":"R11","key":"key20210903112807_b44-etm-0-0-10616","doi-asserted-by":"publisher","DOI":"10.1186\/cc5671","article-title":"Simplified electrophysiological evaluation of peripheral nerves in critically ill patients: The Italian multi-centre CRIMYNE study","volume":"11","author":"Latronico","year":"2007","journal-title":"Crit Care"},{"key":"key20210903112807_b45-etm-0-0-10616","first-page":"1024","article-title":"Clinical approach to the weak patient in the intensive care unit","volume":"51","author":"Dhand","year":"2006","journal-title":"Respir Care"},{"key":"key20210903112807_b46-etm-0-0-10616","doi-asserted-by":"publisher","first-page":"2461","DOI":"10.1093\/brain\/awl191","article-title":"Nerve excitability changes in critical illness polyneuropathy","volume":"129","author":"Z'Graggen","year":"2006","journal-title":"Brain"},{"key":"key20210903112807_b47-etm-0-0-10616","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1017\/S0265021508003505","article-title":"Nerve membrane excitability testing","volume":"42","author":"Z'Graggen","year":"2008","journal-title":"Eur J Anaesthesiol Suppl"},{"issue":"R1","key":"key20210903112807_b48-etm-0-0-10616","doi-asserted-by":"publisher","DOI":"10.1186\/cc5139","article-title":"Neuromuscular deterioration in the early stage of sepsis in rats","volume":"11","author":"Cankayali","year":"2007","journal-title":"Crit Care"},{"key":"key20210903112807_b49-etm-0-0-10616","doi-asserted-by":"publisher","first-page":"S14","DOI":"10.1002\/ana.410370704","article-title":"Guillain-Barr\u00e9 syndrome and chronic inflammatory demyelinating polyneuropathy: Immune mechanisms and update on current therapies","volume":"37 (Suppl 1)","author":"van der Mech\u00e9","year":"1995","journal-title":"Ann Neurol"},{"issue":"7840","key":"key20210903112807_b50-etm-0-0-10616","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21217840","article-title":"Intensive care unit-acquired weakness: Not just another muscle atrophying condition","volume":"21","author":"Lad","year":"2020","journal-title":"Int J Mol Sci"},{"key":"key20210903112807_b51-etm-0-0-10616","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.1378\/chest.06-2065","article-title":"ICU-acquired weakness","volume":"131","author":"Schweickert","year":"2007","journal-title":"Chest"},{"issue":"1977","key":"key20210903112807_b52-etm-0-0-10616","doi-asserted-by":"publisher","DOI":"10.1097\/CCM.0b013e318176aa87","article-title":"Critical illness myopathy: Deeper insights","volume":"36","author":"Young","year":"2008","journal-title":"Crit Care Med"},{"key":"key20210903112807_b53-etm-0-0-10616","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1111\/j.1600-0404.2008.00996.x","article-title":"Predisposing factors for critical illness polyneuromyopathy in a multidisciplinary intensive care unit","volume":"118","author":"Nanas","year":"2008","journal-title":"Acta Neurol Scand"},{"key":"key20210903112807_b54-etm-0-0-10616","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1111\/j.1468-1331.2006.01498.x","article-title":"Critical illness polyneuropathy and myopathy: Clinical features, risk factors and prognosis","volume":"13","author":"Visser","year":"2006","journal-title":"Eur J Neurol"},{"key":"key20210903112807_b55-etm-0-0-10616","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1097\/MCC.0b013e3282efea3a","article-title":"The role of future longitudinal studies in ICU survivors: Understanding determinants and pathophysiology of weakness and neuromuscular dysfunction","volume":"13","author":"Hough","year":"2007","journal-title":"Curr Opin Crit Care"},{"key":"key20210903112807_b56-etm-0-0-10616","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1056\/NEJMoa022450","article-title":"One-year outcomes in survivors of the acute respiratory distress syndrome","volume":"348","author":"Herridge","year":"2003","journal-title":"N Engl J Med"},{"key":"key20210903112807_b57-etm-0-0-10616","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1378\/chest.99.1.176","article-title":"Peripheral nerve function in sepsis and multiple organ failure","volume":"99","author":"Witt","year":"1991","journal-title":"Chest"},{"key":"key20210903112807_b58-etm-0-0-10616","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1111\/ane.12964","article-title":"Risk factors for intensive care unit-acquired weakness: A systematic review and meta-analysis","volume":"138","author":"Yang","year":"2018","journal-title":"Acta Neurol Scand"},{"key":"key20210903112807_b59-etm-0-0-10616","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1007\/s00401-003-0704-3","article-title":"Enhanced expression of E-selectin on the vascular endothelium of peripheral nerve in critically ill patients with neuromuscular disorders","volume":"106","author":"Fenzi","year":"2003","journal-title":"Acta Neuropathol"},{"key":"key20210903112807_b60-etm-0-0-10616","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1097\/CND.0b013e3181b5e14d","article-title":"Neuromuscular disorders in critically ill patients: Review and update","volume":"12","author":"Lacomis","year":"2011","journal-title":"J Clin Neuromuscul Dis"},{"key":"key20210903112807_b61-etm-0-0-10616","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1007\/s00415-004-0272-z","article-title":"Critical illness myopathy serum fractions affect membrane excitability and intracellular calcium release in mammalian skeletal muscle","volume":"251","author":"Friedrich","year":"2004","journal-title":"J Neurol"},{"key":"key20210903112807_b62-etm-0-0-10616","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1113\/jphysiol.2002.035188","article-title":"Crucial role of sodium channel fast inactivation in muscle fibre inexcitability in a rat model of critical illness myopathy","volume":"547","author":"Rich","year":"2003","journal-title":"J Physiol"},{"key":"key20210903112807_b63-etm-0-0-10616","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1097\/CCM.0b013e31816a02cf","article-title":"Endotoxin reduces availability of voltage-gated human skeletal muscle sodium channels at depolarized membrane potentials","volume":"36","author":"Haeseler","year":"2008","journal-title":"Crit Care Med"},{"key":"key20210903112807_b64-etm-0-0-10616","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1136\/jnnp.2007.142430","article-title":"Long-term outcome in patients with critical illness myopathy or neuropathy: The Italian multicentre CRIMYNE study","volume":"79","author":"Guarneri","year":"2008","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"key20210903112807_b65-etm-0-0-10616","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/S0140-6736(02)09459-X","article-title":"Association between mitochondrial dysfunction and severity and outcome of septic shock","volume":"360","author":"Brealey","year":"2002","journal-title":"Lancet"},{"key":"key20210903112807_b66-etm-0-0-10616","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1007\/s001340100890","article-title":"Critical illness polyneuropathy: Clinical findings and cell culture assay of neurotoxicity assessed by a prospective study","volume":"27","author":"Druschky","year":"2001","journal-title":"Intensive Care Med"},{"issue":"1039","key":"key20210903112807_b67-etm-0-0-10616","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2020.01039","article-title":"Neurological aspects of SARS-CoV-2 infection: Mechanisms and manifestations","volume":"11","author":"Guadarrama-Ortiz","year":"2020","journal-title":"Front Neurol"},{"key":"key20210903112807_b68-etm-0-0-10616","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.jaci.2020.04.027","article-title":"Plasma IP-10 and MCP-3 levels are highly associated with disease severity and predict the progression of COVID-19","volume":"146","author":"Yang","year":"2020","journal-title":"J Allergy Clin Immunol"},{"key":"key20210903112807_b69-etm-0-0-10616","doi-asserted-by":"publisher","first-page":"2620","DOI":"10.1172\/JCI137244","article-title":"Clinical and immunological features of severe and moderate coronavirus disease 2019","volume":"130","author":"Chen","year":"2020","journal-title":"J Clin Invest"},{"key":"key20210903112807_b70-etm-0-0-10616","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1097\/00044067-200401000-00006","article-title":"Inactivity and inflammation: Selected cytokines as biologic mediators in muscle dysfunction during critical illness","volume":"15","author":"Winkelman","year":"2004","journal-title":"AACN Clin Issues"},{"key":"key20210903112807_b71-etm-0-0-10616","doi-asserted-by":"crossref","first-page":"65","DOI":"10.31925\/farmacia.2020.1.10","article-title":"Interferon-\u03b2 1A, an immunomodulator in relapsing remitting multiple sclerosis patients. The effect on pro-inflammatory cytokines","volume":"68","author":"Maier","year":"2020","journal-title":"Farmacia"},{"key":"key20210903112807_b72-etm-0-0-10616","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1007\/s40259-020-00430-1","article-title":"Potential role of anti-interleukin (IL)-6 drugs in the treatment of COVID-19: Rationale, clinical evidence and risks","volume":"34","author":"Crisafulli","year":"2020","journal-title":"BioDrugs"},{"key":"key20210903112807_b73-etm-0-0-10616","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1016\/S0140-6736(20)30628-0","article-title":"COVID-19: Consider cytokine storm syndromes and immunosuppression","volume":"395","author":"Mehta","year":"2020","journal-title":"Lancet"},{"key":"key20210903112807_b74-etm-0-0-10616","doi-asserted-by":"publisher","first-page":"2083","DOI":"10.1007\/s00134-020-06244-7","article-title":"Intensive care unit acquired muscle weakness in COVID-19 patients","volume":"46","author":"Van Aerde","year":"2020","journal-title":"Intensive Care Med"},{"issue":"101185","key":"key20210903112807_b75-etm-0-0-10616","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2020.101185","article-title":"Markers of inflammation and their association with muscle strength and mass: A systematic review and meta-analysis","volume":"64","author":"Tuttle","year":"2020","journal-title":"Ageing Res Rev"},{"key":"key20210903112807_b76-etm-0-0-10616","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1002\/jcsm.12589","article-title":"COVID-19: A major cause of cachexia and sarcopenia?","volume":"11","author":"Morley","year":"2020","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"key20210903112807_b77-etm-0-0-10616","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1212\/WNL.0000000000010280","article-title":"Acute myopathic quadriplegia in patients with COVID-19 in the intensive care unit","volume":"95","author":"Madia","year":"2020","journal-title":"Neurology"},{"key":"key20210903112807_b78-etm-0-0-10616","doi-asserted-by":"publisher","first-page":"R1165","DOI":"10.1152\/ajpregu.2000.279.4.R1165","article-title":"NF-kappaB mediates the protein loss induced by TNF-alpha in differentiated skeletal muscle myotubes","volume":"279","author":"Li","year":"2000","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"key20210903112807_b79-etm-0-0-10616","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1096\/fasebj.12.10.971","article-title":"Skeletal muscle myocytes undergo protein loss and reactive oxygen-mediated NF-kappaB activation in response to tumor necrosis factor alpha","volume":"12","author":"Li","year":"1998","journal-title":"FASEB J"},{"key":"key20210903112807_b80-etm-0-0-10616","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1097\/00024382-199904000-00002","article-title":"Mechanism of IL-1 induced inhibition of protein synthesis in skeletal muscle","volume":"11","author":"Cooney","year":"1999","journal-title":"Shock"},{"key":"key20210903112807_b81-etm-0-0-10616","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1097\/CCM.0000000000001402","article-title":"Interleukin-1 receptor blockade is associated with reduced mortality in sepsis patients with features of macrophage activation syndrome: reanalysis of a prior phase III trial","volume":"44","author":"Shakoory","year":"2016","journal-title":"Crit Care Med"},{"key":"key20210903112807_b82-etm-0-0-10616","doi-asserted-by":"publisher","first-page":"1636","DOI":"10.1038\/s41591-020-1051-9","article-title":"An inflammatory cytokine signature predicts COVID-19 severity and survival","volume":"26","author":"Del Valle","year":"2020","journal-title":"Nat Med"},{"key":"key20210903112807_b83-etm-0-0-10616","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1007\/s00134-020-05991-x","article-title":"Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China","volume":"46","author":"Ruan","year":"2020","journal-title":"Intensive Care Med"},{"issue":"300060520955037","key":"key20210903112807_b84-etm-0-0-10616","doi-asserted-by":"publisher","DOI":"10.1177\/0300060520955037","article-title":"Thrombo-inflammatory features predicting mortality in patients with COVID-19: The FAD-85 score","volume":"48","author":"Wang","year":"2020","journal-title":"J Int Med Res"},{"key":"key20210903112807_b85-etm-0-0-10616"},{"key":"key20210903112807_b86-etm-0-0-10616","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1042\/bj3180325","article-title":"Down-regulation of cytokine-induced cyclo-oxygenase-2 transcript isoforms by dexamethasone: Evidence for post-transcriptional regulation","volume":"318","author":"Ristim\u00e4ki","year":"1996","journal-title":"Biochem J"},{"key":"key20210903112807_b87-etm-0-0-10616","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1677\/jme.0.0280069","article-title":"Negative regulation of nuclear factor-kappaB activation and function by glucocorticoids","volume":"28","author":"Almawi","year":"2002","journal-title":"J Mol Endocrinol"},{"key":"key20210903112807_b88-etm-0-0-10616","doi-asserted-by":"publisher","first-page":"e13","DOI":"10.1016\/j.jinf.2020.03.062","article-title":"The effect of corticosteroid treatment on patients with coronavirus infection: A systematic review and meta-analysis","volume":"81","author":"Yang","year":"2020","journal-title":"J Infect"},{"key":"key20210903112807_b89-etm-0-0-10616","doi-asserted-by":"publisher","first-page":"913","DOI":"10.4103\/2230-8210.117215","article-title":"Glucocorticoid-induced myopathy: Pathophysiology, diagnosis, and treatment","volume":"17","author":"Gupta","year":"2013","journal-title":"Indian J Endocrinol Metab"},{"key":"key20210903112807_b90-etm-0-0-10616","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1038\/s41423-020-0447-2","article-title":"High-dimensional immune profiling by mass cytometry revealed immunosuppression and dysfunction of immunity in COVID-19 patients","volume":"17","author":"Wang","year":"2020","journal-title":"Cell Mol Immunol"},{"issue":"827","key":"key20210903112807_b91-etm-0-0-10616","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.00827","article-title":"Reduction and functional exhaustion of T cells in patients with coronavirus disease 2019 (COVID-19)","volume":"11","author":"Diao","year":"2020","journal-title":"Front Immunol"},{"key":"key20210903112807_b92-etm-0-0-10616","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1002\/ags3.12194","article-title":"Mechanisms of sepsis-induced immunosuppression and immunological modification therapies for sepsis","volume":"2","author":"Ono","year":"2018","journal-title":"Ann Gastroenterol Surg"},{"key":"key20210903112807_b93-etm-0-0-10616","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1001\/jamaneurol.2020.1127","article-title":"Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China","volume":"77","author":"Mao","year":"2020","journal-title":"JAMA Neurol"},{"key":"key20210903112807_b94-etm-0-0-10616","doi-asserted-by":"publisher","first-page":"E247","DOI":"10.1152\/ajpendo.00206.2001","article-title":"Plasma L-5-oxoproline kinetics and whole blood glutathione synthesis rates in severely burned adult humans","volume":"282","author":"Yu","year":"2002","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"key20210903112807_b95-etm-0-0-10616","doi-asserted-by":"publisher","first-page":"1813","DOI":"10.1056\/NEJMoa2007764","article-title":"Remdesivir for the treatment of Covid-19-final report","volume":"383","author":"Beigel","year":"2020","journal-title":"N Engl J Med"},{"key":"key20210903112807_b96-etm-0-0-10616","doi-asserted-by":"publisher","first-page":"2042","DOI":"10.1002\/jmv.25964","article-title":"Tocilizumab for the treatment of severe coronavirus disease 2019","volume":"92","author":"Alattar","year":"2020","journal-title":"J Med Virol"},{"key":"key20210903112807_b97-etm-0-0-10616","doi-asserted-by":"publisher","first-page":"1727","DOI":"10.1126\/science.1206936","article-title":"The Hedgehog pathway promotes blood-brain barrier integrity and CNS immune quiescence","volume":"334","author":"Alvarez","year":"2011","journal-title":"Science"},{"key":"key20210903112807_b98-etm-0-0-10616","doi-asserted-by":"publisher","first-page":"e465","DOI":"10.1016\/S2665-9913(20)30170-3","article-title":"GM-CSF blockade with mavrilimumab in severe COVID-19 pneumonia and systemic hyperinflammation: A single-centre, prospective cohort study","volume":"2","author":"De Luca","year":"2020","journal-title":"Lancet Rheumatol"},{"key":"key20210903112807_b99-etm-0-0-10616","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/S2213-2600(19)30417-5","article-title":"Dexamethasone treatment for the acute respiratory distress syndrome: A multicentre, randomised controlled trial","volume":"8","author":"Villar","year":"2020","journal-title":"Lancet Respir Med"},{"key":"key20210903112807_b100-etm-0-0-10616","doi-asserted-by":"crossref","first-page":"426","DOI":"10.31925\/farmacia.2020.3.7","article-title":"Understandig the mechanism of action of intravenous immunoglobulins: A ten years experience in treating Guillain-Barr\u00e9syndrome","volume":"68","author":"Stoian","year":"2020","journal-title":"Farmacia"},{"key":"key20210903112807_b101-etm-0-0-10616","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1086\/525263","article-title":"Respiratory syncytial virus infection in patients with hematological diseases: Single-center study and review of the literature","volume":"46","author":"Khanna","year":"2008","journal-title":"Clin Infect Dis"},{"key":"key20210903112807_b102-etm-0-0-10616","doi-asserted-by":"publisher","first-page":"818","DOI":"10.3201\/eid1005.030640","article-title":"Clinical manifestations, laboratory findings, and treatment outcomes of SARS patients","volume":"10","author":"Wang","year":"2004","journal-title":"Emerg Infect Dis"},{"key":"key20210903112807_b103-etm-0-0-10616","doi-asserted-by":"publisher","first-page":"389","DOI":"10.7326\/M13-2486","article-title":"Clinical course and outcomes of critically ill patients with Middle East respiratory syndrome coronavirus infection","volume":"160","author":"Arabi","year":"2014","journal-title":"Ann Intern Med"},{"issue":"R213","key":"key20210903112807_b104-etm-0-0-10616","doi-asserted-by":"publisher","DOI":"10.1186\/cc13028","article-title":"Early treatment with IgM-enriched intravenous immunoglobulin does not mitigate critical illness polyneuropathy and\/or myopathy in patients with multiple organ failure and SIRS\/sepsis: A prospective, randomized, placebo-controlled, double-blinded trial","volume":"17","author":"Brunner","year":"2013","journal-title":"Crit Care"},{"key":"key20210903112807_b105-etm-0-0-10616","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.1007\/s001340050471","article-title":"Effects of early treatment with immunoglobulin on critical illness polyneuropathy following multiple organ failure and gram-negative sepsis","volume":"23","author":"Mohr","year":"1997","journal-title":"Intensive Care Med"},{"key":"key20210903112807_b106-etm-0-0-10616","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1002\/mus.24175","article-title":"Long-term recovery In critical illness myopathy is complete, contrary to polyneuropathy","volume":"50","author":"Koch","year":"2014","journal-title":"Muscle Nerve"},{"key":"key20210903112807_b107-etm-0-0-10616","first-page":"319","article-title":"Critical illness myopathy and neuropathy","volume":"74","author":"Latronico","year":"2008","journal-title":"Minerva Anestesiol"},{"key":"key20210903112807_b108-etm-0-0-10616","doi-asserted-by":"publisher","first-page":"S49","DOI":"10.1002\/1097-4598(2000)999:9<::aid-mus9>3.0.co;2-9","article-title":"Long-term outcome of critical illness polyneuropathy","volume":"9","author":"Zifko","year":"2000","journal-title":"Muscle Nerve Suppl"},{"key":"key20210903112807_b109-etm-0-0-10616","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1097\/01.CCM.0000053651.38421.D9","article-title":"Persistent neuromuscular and neurophysiologic abnormalities in long-term survivors of prolonged critical illness","volume":"31","author":"Fletcher","year":"2003","journal-title":"Crit Care Med"},{"key":"key20210903112807_b110-etm-0-0-10616","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1159\/000008137","article-title":"Critical illness polyneuropathy. A 2-year follow-up study in 19 severe cases","volume":"43","author":"de S\u00e8ze","year":"2000","journal-title":"Eur Neurol"},{"key":"key20210903112807_b111-etm-0-0-10616","doi-asserted-by":"publisher","first-page":"R358","DOI":"10.1186\/cc2925","article-title":"Combination of histopathological and electromyographic patterns can help to evaluate functional outcome of critical ill patients with neuromuscular weakness syndromes","volume":"8","author":"Kerbaul","year":"2004","journal-title":"Crit Care"},{"key":"key20210903112807_b112-etm-0-0-10616","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1056\/NEJMoa1011802","article-title":"Functional disability 5 years after acute respiratory distress syndrome","volume":"364","author":"Herridge","year":"2011","journal-title":"N Engl J Med"},{"key":"key20210903112807_b113-etm-0-0-10616","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/j.jocn.2020.07.058","article-title":"Approach to critical illness myopathy and polyneuropathy in the older SARS-CoV-2 patients","volume":"79","author":"McClafferty","year":"2020","journal-title":"J Clin Neurosci"},{"key":"key20210903112807_b114-etm-0-0-10616","doi-asserted-by":"publisher","first-page":"1669","DOI":"10.1001\/archneur.61.11.1669","article-title":"Neuromuscular disorders in severe acute respiratory syndrome","volume":"61","author":"Tsai","year":"2004","journal-title":"Arch Neurol"},{"issue":"ofaa102","key":"key20210903112807_b115-etm-0-0-10616","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofaa102","article-title":"High-dose intravenous immunoglobulin as a therapeutic option for deteriorating patients with coronavirus disease 2019","volume":"7","author":"Cao","year":"2020","journal-title":"Open Forum Infect Dis"},{"key":"key20210903112807_b116-etm-0-0-10616","doi-asserted-by":"publisher","first-page":"2052","DOI":"10.1001\/jama.2020.6775","article-title":"Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York City Area","volume":"323","author":"Richardson","year":"2020","journal-title":"JAMA"},{"issue":"2003006","key":"key20210903112807_b117-etm-0-0-10616","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.03006-2020","article-title":"Confronting the controversy: Interleukin-6 and the COVID-19 cytokine storm syndrome","volume":"56","author":"Chen","year":"2020","journal-title":"Eur Respir J"},{"key":"key20210903112807_b118-etm-0-0-10616","author":"Shimizu"},{"key":"key20210903112807_b119-etm-0-0-10616","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1038\/s41586-020-2588-y","article-title":"Longitudinal analyses reveal immunological misfiring in severe COVID-19","volume":"584","author":"Lucas","year":"2020","journal-title":"Nature"},{"key":"key20210903112807_b120-etm-0-0-10616","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1016\/j.cell.2020.04.026","article-title":"Imbalanced host response to SARS-CoV-2 drives development of COVID-19","volume":"181","author":"Blanco-Melo","year":"2020","journal-title":"Cell"},{"key":"key20210903112807_b121-etm-0-0-10616","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1111\/bjh.15579","article-title":"Extreme hyperferritinaemia, soluble interleukin-2 receptor, and haemophagocytic lymphohistiocytosis","volume":"185","author":"Chen","year":"2019","journal-title":"Br J Haematol"},{"key":"key20210903112807_b122-etm-0-0-10616","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1016\/j.chom.2020.04.009","article-title":"Complex immune dysregulation in COVID-19 patients with severe respiratory failure","volume":"27","author":"Giamarellos-Bourboulis","year":"2020","journal-title":"Cell Host Microbe"},{"key":"key20210903112807_b123-etm-0-0-10616","doi-asserted-by":"publisher","first-page":"4694","DOI":"10.1172\/JCI138554","article-title":"Impaired immune cell cytotoxicity in severe COVID-19 is IL-6 dependent","volume":"130","author":"Mazzoni","year":"2020","journal-title":"J Clin Invest"},{"key":"key20210903112807_b124-etm-0-0-10616","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1056\/NEJMoa2021436","article-title":"Dexamethasone in Hospitalized Patients with Covid-19","volume":"384","author":"Horby","year":"2021","journal-title":"N Engl J Med"},{"key":"key20210903112807_b125-etm-0-0-10616","doi-asserted-by":"publisher","first-page":"1589","DOI":"10.1016\/j.clinph.2020.04.011","article-title":"Guidance for clinical neurophysiology examination throughout the COVID-19 pandemic. Latin American chapter of the IFCN task force-COVID-19","volume":"131","author":"San-Juan","year":"2020","journal-title":"Clin Neurophysiol"},{"key":"key20210903112807_b126-etm-0-0-10616","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1164\/rccm.201411-2011ST","article-title":"An official American Thoracic Society Clinical Practice guideline: The diagnosis of intensive care unit-acquired weakness in adults","volume":"190","author":"Fan","year":"2014","journal-title":"Am J Respir Crit Care Med"},{"key":"key20210903112807_b127-etm-0-0-10616","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1164\/rccm.201205-0954SO","article-title":"Intensive care unit-acquired weakness: Clinical phenotypes and molecular mechanisms","volume":"187","author":"Batt","year":"2013","journal-title":"Am J Respir Crit Care Med"},{"key":"key20210903112807_b128-etm-0-0-10616","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1097\/WNP.0000000000000652","article-title":"Critical illness myopathy","volume":"37","author":"Z'Graggen","year":"2020","journal-title":"J Clin Neurophysiol"},{"issue":"265","key":"key20210903112807_b129-etm-0-0-10616","doi-asserted-by":"publisher","DOI":"10.3892\/etm.2021.9696","article-title":"Therapeutic plasma exchange as a first-choice therapy for axonal Guillain-Barr\u00e9 syndrome: A case-based review of the literature (Review)","volume":"21","author":"Stoian","year":"2021","journal-title":"Exp Ther Med"},{"issue":"29","key":"key20210903112807_b130-etm-0-0-10616","doi-asserted-by":"publisher","DOI":"10.21037\/atm.2017.12.12","article-title":"Models of disuse muscle atrophy: Therapeutic implications in critically ill patients","volume":"6","author":"Barreiro","year":"2018","journal-title":"Ann Transl Med"},{"key":"key20210903112807_b131-etm-0-0-10616","doi-asserted-by":"publisher","first-page":"1844","DOI":"10.1007\/s00134-017-4758-4","article-title":"Mechanism of ICU-acquired weakness: Skeletal muscle loss in critical illness","volume":"43","author":"Batt","year":"2017","journal-title":"Intensive Care Med"},{"key":"key20210903112807_b132-etm-0-0-10616","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1016\/j.ccc.2018.06.010","article-title":"The pathophysiology of neuromuscular dysfunction in critical illness","volume":"34","author":"Parotto","year":"2018","journal-title":"Crit Care Clin"},{"key":"key20210903112807_b133-etm-0-0-10616","doi-asserted-by":"publisher","first-page":"74","DOI":"10.2478\/jccm-2020-0008","article-title":"Guillain-barr\u00e9 and acute transverse myelitis overlap syndrome following obstetric surgery","volume":"6","author":"Stoian","year":"2020","journal-title":"J Crit Care Med (Targu Mures)"},{"key":"key20210903112807_b134-etm-0-0-10616","doi-asserted-by":"publisher","first-page":"241","DOI":"10.3233\/JND-140066","article-title":"Muscle-derived proteins as serum biomarkers for monitoring disease progression in three forms of muscular dystrophy","volume":"2","author":"Burch","year":"2015","journal-title":"J Neuromuscul Dis"},{"issue":"960363","key":"key20210903112807_b135-etm-0-0-10616","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/960363","article-title":"Creatine-kinase- and exercise-related muscle damage implications for muscle performance and recovery","volume":"2012","author":"Baird","year":"2012","journal-title":"J Nutr Metab"},{"key":"key20210903112807_b136-etm-0-0-10616","doi-asserted-by":"publisher","first-page":"306","DOI":"10.5535\/arm.2017.41.2.306","article-title":"Correlation of serum creatine kinase level with pulmonary function in Duchenne muscular dystrophy","volume":"41","author":"Kim","year":"2017","journal-title":"Ann Rehabil Med"},{"issue":"107205","key":"key20210903112807_b137-etm-0-0-10616","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2020.107205","article-title":"Evaluating the effects of Intravenous Immunoglobulin (IVIg) on the management of severe COVID-19 cases: A randomized controlled trial","volume":"90","author":"Tabarsi","year":"2021","journal-title":"Int Immunopharmacol"},{"issue":"A281","key":"key20210903112807_b138-etm-0-0-10616","article-title":"A recovered case of COVID-19 myocarditis treated with IV immunoglobulin","volume":"158","author":"Jain","year":"2020","journal-title":"Chest"},{"key":"key20210903112807_b139-etm-0-0-10616","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1093\/intimm\/dxx039","article-title":"IVIG-mediated effector functions in autoimmune and inflammatory diseases","volume":"29","author":"Galeotti","year":"2017","journal-title":"Int Immunol"},{"key":"key20210903112807_b140-etm-0-0-10616","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s00415-008-3002-0","article-title":"Advances in the understanding of the mechanism of action of IVIg","volume":"255 (Suppl 3)","author":"Hartung","year":"2008","journal-title":"J Neurol"},{"key":"key20210903112807_b141-etm-0-0-10616","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1007\/s10096-005-0004-z","article-title":"Treatment of severe acute respiratory syndrome","volume":"24","author":"Lai","year":"2005","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"key20210903112807_b142-etm-0-0-10616","doi-asserted-by":"publisher","first-page":"89","DOI":"10.2478\/jccm-2020-0021","article-title":"Therapeutic plasma exchange: An indispensable therapy for severe neurological condition","volume":"6","author":"Balasa","year":"2020","journal-title":"J Crit Care Med (Targu Mures)"},{"key":"key20210903112807_b143-etm-0-0-10616","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1378\/chest.12-2907","article-title":"Hyperimmune IV immunoglobulin treatment: A multicenter double-blind randomized controlled trial for patients with severe 2009 influenza A(H1N1) infection","volume":"144","author":"Hung","year":"2013","journal-title":"Chest"},{"issue":"108459","key":"key20210903112807_b144-etm-0-0-10616","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2020.108459","article-title":"Immunoglobulins in the treatment of COVID-19 infection: Proceed with caution! Clin","volume":"216","author":"Nguyen","year":"2020","journal-title":"Immunol"},{"key":"key20210903112807_b145-etm-0-0-10616","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1016\/j.jinf.2020.03.044","article-title":"Effect of regular intravenous immunoglobulin therapy on prognosis of severe pneumonia in patients with COVID-19","volume":"81","author":"Xie","year":"2020","journal-title":"J Infect"},{"key":"key20210903112807_b146-etm-0-0-10616","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1016\/j.cmi.2020.10.010","article-title":"Outcome of hospitalized patients with COVID-19 pneumonia treated with high-dose immunoglobulin therapy in a prospective case series","volume":"27","author":"Reynaga","year":"2021","journal-title":"Clin Microbiol Infect"},{"key":"key20210903112807_b147-etm-0-0-10616","first-page":"559","article-title":"Intravenous immunoglobulin in septic shock: Review of the mechanisms of action and meta-analysis of the clinical effectiveness","volume":"82","author":"Busani","year":"2016","journal-title":"Minerva Anestesiol"},{"key":"key20210903112807_b148-etm-0-0-10616","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1038\/nri3401","article-title":"Intravenous immunoglobulin therapy: How does IgG modulate the immune system?","volume":"13","author":"Schwab","year":"2013","journal-title":"Nat Rev Immunol"},{"key":"key20210903112807_b149-etm-0-0-10616","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1016\/S2213-2600(19)30253-X","article-title":"Anti-influenza hyperimmune intravenous immunoglobulin for adults with influenza A or B infection (FLU-IVIG): A double-blind, randomised, placebo-controlled trial","volume":"7","author":"Davey","year":"2019","journal-title":"Lancet Respir Med"},{"key":"key20210903112807_b150-etm-0-0-10616","doi-asserted-by":"publisher","first-page":"1631","DOI":"10.3892\/ijmm.2020.4555","article-title":"A new threat from an old enemy: Re-emergence of coronavirus (Review)","volume":"45","author":"Docea","year":"2020","journal-title":"Int J Mol Med"},{"key":"key20210903112807_b151-etm-0-0-10616","doi-asserted-by":"publisher","first-page":"3","DOI":"10.3892\/ijmm.2020.4596","article-title":"Towards effective COVID-19 vaccines: Updates, perspectives and challenges (Review)","volume":"46","author":"Calina","year":"2020","journal-title":"Int J Mol Med"}],"container-title":["Experimental and Therapeutic Medicine"],"original-title":[],"deposited":{"date-parts":[[2021,9,6]],"date-time":"2021-09-06T19:25:48Z","timestamp":1630956348000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.spandidos-publications.com\/10.3892\/etm.2021.10616"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,16]]},"references-count":151,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2021,8,16]]}},"URL":"https:\/\/doi.org\/10.3892\/etm.2021.10616","relation":{},"ISSN":["1792-0981","1792-1015"],"issn-type":[{"value":"1792-0981","type":"print"},{"value":"1792-1015","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,8,16]]},"article-number":"1182"}}